Clinical Trial Update: Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cemiplimab with or without fianlimab in older patients with localized or locally advanced MSI-H colorectal cancer is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING